Hippocampal, amygdala and nucleus accumbens volume in first-episode schizophrenia patients and individuals at high familial risk: A cross-sectional comparison

Schizophrenia Research

Volumn 165, Issue 1, 2015, Pages 45-51

  Bois, Catherine ^a   Levita, Liat ^b   Ripp, Isabelle ^c   Owens, David C G ^a   Johnstone, Eve C ^a   Whalley, Heather C ^a   Lawrie, Stephen M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Amygdala; High risk; Hippocampus; Nucleus accumbens; Schizophrenia; Structural MRI

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; FEMALE; FIRST EPISODE SCHIZOPHRENIA; GRAY MATTER; HIGH RISK PATIENT; HIPPOCAMPUS; HUMAN; LEFT HEMISPHERE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RIGHT HEMISPHERE; SCHIZOPHRENIA; YOUNG ADULT; AMYGDALA; ANALYSIS OF VARIANCE; HEMISPHERIC DOMINANCE; IMAGE PROCESSING; PATHOLOGY; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AMYGDALA; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; FEMALE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NUCLEUS ACCUMBENS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84929517348     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.03.024     Document Type: Article

References (56)

1. American Psychiatric Association Diagnostic and statisticalmanualof mental disorders: DSM-IV-TR, 4th ed. American Psychiatric Association 2000, Washington, DC.
2. Arnold S.J.M., Ivleva E.I., Gopal T.A., Reddy A.P., Jeon-Slaughter H., Sacco C.B., et al. Hippocampal volume is reduced in schizophrenia and schizoaffective disorder but not in psychotic bipolar i disorder demonstrated by both manual tracing and automated parcellation (FreeSurfer). Schizophr. Bull. 2015, 41(1).
3. Atkins M., Burgess A., Bottomley C., Riccio M. Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications. Psychiatr. Bull. 1997, 21:224-226.
4. Babalola K.O., Patenaude B., Aljabar P., et al. An evaluation of four automatic methods of segmenting the subcortical structures in the brain. NeuroImage 2009, 47(4):1435-1447.
5. Belujon P., Patton M.H., Grace A.A. Role of the prefrontal cortex in altered hippocampal-accumbens synaptic plasticity in a developmental animal model of schizophrenia. Cereb. Cortex 2014, 24(4):968-977.
6. Bogerts B., Lieberman J.A., Ashtari M., et al. Hippocampus, amygdala volumes and psychopathology in chronic schizophrenia. Biol. Psychiatry 1993, 33(4):236-246.
7. Bois C., Whalley H.C., McIntosh A.M., et al. Structural magnetic resonance imaging markers of susceptibility and transition to schizophrenia: a review of familial and clinical high risk populations. J. Psychopharmacol. 2014, 29(2):144-154.
8. Bois C., Ronan L., Levita L., et al. Cortical surface area differentiates familial high risk individuals who go on to develop schizophrenia. Biol. Psychiatry. 2015, (in press). 10.1016/j.biopsych.2014.12.030.
9. Cannon T.D., Thompson P.M., van Erp T.G.M., et al. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. PNAS 2002, 99(9):3228-3233.
10. Cannon T.D., Chung Y., He G., Sun D., Jacobson A., van Erp T.G.M., et al. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol. Psychiatry 2015, 77(2):147-157.
11. Chakos M.H., Schobel S.A., Gu H., Gerig G., Bradford D., Charles C., et al. Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. Br. J. Psychiatr. 2005, 186(1):26-31.
12. Chau D.T., Roth R.M., Green A.I. The neural circuitry of reward and its relevance to psychiatric disorders. Curr. Psychiatr. Rep. 2004, 6(5):391-399.
13. Cooper D., Barker V., Radua J., et al. Multimodal voxel-based meta-analysis of structural and functional magnetic resonance imaging studies in those at elevated genetic risk of developing schizophrenia. Psychiatr. Res. 2014, 221:69-77.
14. Dere E., Pause B.M., Pietrowsky R. Emotion and episodic memory in neuropsychiatric disorders. Behav. Brain Res. 2010, 215(2):162-171.
15. Duvernoy H.M. The Human Brain. Surface Three-dimensional Sectional Anatomy and MRI 1991, Springer-Verlag, New York.
16. Exner C., Boucsein K., Degner D., et al. Impaired emotional learning and reduced amygdala size in schizophrenia: a 3-month follow-up. Schizophr. Res. 2004, 71(3):493-503.
17. Fischl B., Salt D.H., Busa E., et al. Whole brain segmentation: automated labelling of neuroanatomical structures in the human brain. Neuron 2002, 33(3):341-355.
18. Fusar-Poli P., Borgwardt S., Crescini A., et al. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci. Biobehav. Rev. 2011, 35:1175-1185.
19. Ganzola R., Maziade M., Duchesne Hippocampus and amygdala volumes in children and young adults at high-risk of schizophrenia: research synthesis. Schizophr. Res. 2014, 156(1):76-86.
20. Grace A.A. Gating within limbic-cortical circuits and its alteration in a developmental disruption model of schizophrenia. Clin. Neurosci. Res. 2003, 3(4-5):333-338.
21. Greer S.M., Trujillo A.J., Glover G.H., Knutson B. Control of nucleus accumbens activity with neurofeedback. NeuroImage 2014, 96(1):237-244.
22. Haijma S.V., Van Haren N., Cahn W., Koolschikn P.C.M.P., Hulshoff Pol H.E., Kahn R.S. Brain volumes in schizophrenia: a meta-analysis in over 18000 subjects. Schizophr. Bull. 2013, 39(5):1129-1138.
23. Hall J., Whalley H.C., Marwick K., McKirdy J., Sussmann J., Romaniuk L., et al. Hippocampal function in schizophrenia and bipolar disorder. Psychol. Med. 2010, 40(5):761-770.
24. Heckers S., Konradi C. Hippocampal neurons in schizophrenia. J. Neural Transm. 2002, 109(6):891-905.
25. Herold C.J., Lasser M.M., Schimd L.A., Seidl L.A., Kong L., Felhauer I., et al. Hippocampal volume reduction and autobiographical memory deficits in chronic schizophrenia. Psychiatr. Res. 2013, 211(3):189-194.
26. Hodges A., Byrne M., Grant E., et al. People at risk of schizophrenia. Sample characteristics of the first 100 cases in the Edinburgh High-Risk study. Br. J. Psychiatr. 2000, 174:547-553.
27. Job D.E., Whalley H.C., McConnell S., et al. Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia. Schizophr. Res. 2003, 64(1):1-13.
28. Job D.E., Whalley H.C., Johnstone E.C., et al. Grey matter changes over time in high risk subjects developing schizophrenia. NeuroImage 2005, 25(4):1023-1030.
29. Johnstone E.C., Abukmeil S.S., Byrne M., et al. Edinburgh high risk study-findings after four years: demographic, attainment and psychopathological issues. Schizophr. Res. 2000, 46(1):1-15.
30. Kreczmanski P., Heinsen H., Mantua V., Woltersdorf F., Masson T., Ulfig N., et al. Volume, neuron density and total neuron number in five subcortical regions in schizophrenia. Brain 2007, 130(3):678-692.
31. Lappin J.M., Morgan C., Chalavi C., et al. Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes. Psychol. Med. 2014, 44(6):1279-1291.
32. Lauer M., Senitz D., Beckmann H. Increased volume of the nucleus accumbens in schizophrenia. J. Neural Transm. 2001, 108:645-660.
33. Lawrie S.M., Whalley H., Kestelman J.N., Abukmeil S.S., Byrne M., Hodges A., et al. Magnetic resonance imaging of brain in people at high risk at high risk of developing schizophrenia. Lancet 1999, 353(9146):30-33.
34. Lawrie S.M., Whalley H.C., Job D.E., et al. Structural and functional abnormalities of the amygdala in schizophrenia. Ann. N. Y. Acad. Sci. 2006, 985:445-460.
35. Lawrie S.M., McIntosh A.M., Hall J., et al. Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk. Schizophr. Bull. 2008, 34(2):330-340.
36. McGuffin P., Farmer A., Harvey I., et al. A polydiagnostic application of operational criteria in studies of psychotic illness; development and reliability of the OPCRIT System. JAMA Psych. 1991, 48(8):764-770.
37. Moore H., West A.R., Grace A.A. The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia. Biol. Psychiatry 1999, 46(1):40-55.
38. Pantelis C., Velakoulis D., McGorry P.D., et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003, 361:281-288.
39. Pantelis C., Yucel M., Wood S.J., et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr. Bull. 2005, 31(3):672-696.
40. Phillips R.G., LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 1992, 106(2):274-285.
41. Qui A., Gan S.C., Wang Y., et al. Amygdala hippocampal shape and cortical thickness abnormalities in first-episode schizophrenia and mania. Psychol. Med. 2013, 43(7):1353-1363.
42. Seidman L.J., Faraone S.V., Goldstein J.M., et al. Thalamic and amygdala-hippocampal volume reductions in first-degree relatives of patients with schizophrenia: an MRI-based morphometric analysis. Biol. Psychiatry 1999, 46(7):941-954.
43. Smieksova R., Marmy J., Schmidt A., et al. Do subjects at clinical high risk for psychosis differ from those with a genetic high risk? A systematic review of structural and functional brain abnormalities. Curr. Med. Chem. 2013, 20:467-481.
44. Sprooten E., Papmeyer M., Smyth A.M., et al. Cortical thickness in first-episode schizophrenia patients and induviduals at high familial risk: a cross-sectional comparison. Schiz. Res. 2013, 151(1-3):259-264.
45. Staal W.G., Hulshoff Pol H.E., Schnack H.G., Hoogendoorn M.L.C., Jellema K., Kahn R. Structural brain abnormalities in patients with schizophrenia and their healthy siblings. Am. J. Psychiatry 2000, 157(3):416-421.
46. Stefanis N., Frangou S., Yakeley J., Sharma T., O'Connell P., Morgan K., et al. Hippocampal volume reduction in schizophrenia: effects of genetic risk and pregnancy and birth complications. Biol. Psychiatry 1999, 46(5):697-702.
47. Sun D., Phillips L., Velakoulis D., Yung A., McGorry P.D., Wood S.J., et al. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr. Res. 2009, 108(1-3):85-92.
48. Tanskanen P., Veijola J.M., Piippo U.K., Haapea M., Meittunen J.A., Pyhtinen J., et al. Hippocampus and amygdala volumes in schizophrenia and other psychoses in the northern Finland 1966 birth cohort. Schizophr. Res. 2005, 75(2-3):283-294.
49. Velakoulis D., Wood S.J., Wong M.T.H., McGorry P.D., Yung A., Phillips L., et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis. A magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis and ultra-high risk individuals. JAMA Psych. 2006, 63(2):139-149.
50. Watson D.R., Bai F., Barrett S.L., Turkington A., Rushe T.M., Mulholland C.C., et al. Structural changes in the hippocampus and amygdala at first episode of psychosis. Brain Imaging Behav. 2012, 6(1):49-60.
51. Whalley H.C., Simonotto E., Flett S., Marshall I., Ebmeier K.P., Owens D.G.C. fMRI correlates of state and trait effects in subjects at genetically enhanced risk of schizophrenia. Brain 2004, 127(3):478-490.
52. Whalley H.C., Harris J.C., Lawrie S.M. The neurobiological underpinnings of risk and conversion in relatives of patients with schizophrenia. Int. Rev. Psychiatry 2007, 19(4):383-397.
53. Whalley H.C., Papmeyer M., Sprooten E., Lawrie S.M., Sussmann J.E., McIntosh A.M. Review of functional magnetic resonance imaging studies comparing bipolar disorder and schizophrenia. Bipolar Disord. 2012, 14(4):411-431.
54. Wing J.K., Cooper J.E., Sartorius N., et al. Measurement and Classification of Psychiatric Symptoms, an Instruction Manual for the PSE and CATEGO Programme 1974, Cambridge University Press, Cambridge.
55. Womer F.Y., Wang L., Alpert K.I., Smith M.J., Csernansky J.G., Barch D.M., et al. Basal ganglia and thalamic morphology in schizophrenia and bipolar disorder. Psychiatr. Res. 2014, 223:75-83.
56. Woods S.W. Chlorpromazine equivilant doses for the newer atypical antipsychotics. J. Clin. Psychiatry. 2003, 64(6):663-667.